Lower GI 2016

HIV & ANAL CANCER

Historically ( pre-HAART ) anal carcinoma treatment in HIV positive patients associated with lower response rate and reduced survival

Radiotherapy and chemotherapy poorly tolerated with more toxicity and breaks in treatment

More recent studies ( post HAART ) suggest outcomes equivalent to non-HIV+ patients